Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Collet

Showing results (1-10 of 408) with videos related to

Pageof 41
Sort By:
Interventional Cardiology (London, England)|March 29, 2018
Current Concepts in the Clinical Utility of Platelet Reactivity TestingJean-Philippe Collet
JACC. Cardiovascular Interventions|January 4, 2023
Timing of Invasive Coronary Angiography in NSTEMIJean-Philippe Collet, Sripal Bangalore
European Heart Journal|July 12, 2005
Preserving cardiac function in the hypertensive patient: why renal parameters hold the keyGilles Montalescot, Jean-Philippe Collet
Fundamental & Clinical Pharmacology|September 8, 2011
Clinical effects and outcomes with new P2Y12 inhibitors in ACSJean-Philippe Collet, Stephen O'Connor
European Heart Journal|November 18, 2020
Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?Jean-Philippe Collet, Holger Thiele
Presse Medicale (Paris, France : 1983)|December 15, 2018
[Aortic stenosis in the elderly: The TAVI revolution]Pavel Overtchouk, Jean-Philippe Collet
European Heart Journal|October 21, 2020
The 'Ten Commandments' for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationJean-Philippe Collet, Holger Thiele
Thrombosis and Haemostasis|January 28, 2021
Antithrombotic Therapy in Acute Coronary Syndromes: Current Evidence and Ongoing Issues Regarding Early and Late ManagementPaul Guedeney, Jean-Philippe Collet
JACC. Cardiovascular Interventions|June 20, 2020
Vascular Access Site for TAVR: Use the Approach You Master BestJules Mesnier, Jean Philippe Collet
Nature Clinical Practice. Nephrology|October 27, 2006
Does severe renal insufficiency increase the risk of bleeding after administration of low-molecular-weight heparin?Jean-Philippe Collet, Gilles Montalescot
Pageof 41

Showing results (1-10 of 408) with videos related to

Sort By:
Pageof 41
Interventional Cardiology (London, England)|March 29, 2018
Current Concepts in the Clinical Utility of Platelet Reactivity TestingJean-Philippe Collet
JACC. Cardiovascular Interventions|January 4, 2023
Timing of Invasive Coronary Angiography in NSTEMIJean-Philippe Collet, Sripal Bangalore
European Heart Journal|July 12, 2005
Preserving cardiac function in the hypertensive patient: why renal parameters hold the keyGilles Montalescot, Jean-Philippe Collet
Fundamental & Clinical Pharmacology|September 8, 2011
Clinical effects and outcomes with new P2Y12 inhibitors in ACSJean-Philippe Collet, Stephen O'Connor
European Heart Journal|November 18, 2020
Prasugrel over ticagrelor in non-ST-elevation acute coronary syndromes: is it justified?Jean-Philippe Collet, Holger Thiele
Presse Medicale (Paris, France : 1983)|December 15, 2018
[Aortic stenosis in the elderly: The TAVI revolution]Pavel Overtchouk, Jean-Philippe Collet
European Heart Journal|October 21, 2020
The 'Ten Commandments' for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationJean-Philippe Collet, Holger Thiele
Thrombosis and Haemostasis|January 28, 2021
Antithrombotic Therapy in Acute Coronary Syndromes: Current Evidence and Ongoing Issues Regarding Early and Late ManagementPaul Guedeney, Jean-Philippe Collet
JACC. Cardiovascular Interventions|June 20, 2020
Vascular Access Site for TAVR: Use the Approach You Master BestJules Mesnier, Jean Philippe Collet
Nature Clinical Practice. Nephrology|October 27, 2006
Does severe renal insufficiency increase the risk of bleeding after administration of low-molecular-weight heparin?Jean-Philippe Collet, Gilles Montalescot
Pageof 41